Familial hypercholesterolemia complicated with multiple xanthomas in a child: a case report

Familial hypercholesterolemia (FH) is a hereditary disorder primarily due to variants of low-density lipoprotein receptor (LDLR) gene, characterized by markedly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels and a severely increased risk of premature atherosclerotic cardiovascular disease (ASCVD). For rare homozygous FH (HoFH), the condition is particularly severe and the treatment is extremely challenging. This case described a pediatric HoFH patient presenting with multiple xanthomas and a LDL-C level of 17.95 mmol/L (694.04 mg/dL). Genetic testing further revealed compound heterozygous variants in the LDLR gene: a missense variant (NM_000527.5:c.298G>A) and a classic splicing variant (NM_000527.5:c.817+1G>A), confirming the diagnosis of biallelic semidominant hypercholesterolemia, monogenic (same gene, different variants). The patient received triple combination therapy with atorvastatin, ezetimibe and evolocumab, and actively improved his lifestyle. After nearly two years of follow-up, his LDL-C levels decreased from baseline to 14.23 mmol/L (550.59 mg/dL). However, this failed to reach the therapeutic goal and cutaneous xanthomas at the joints showed no significant regression. For such patients with severe defects in LDLR function, agents independent of LDLR pathway, LDL apheresis, or even liver transplantation should be initiated early to improve long-term prognosis. This report underscores the role of prioritizing phenotypic identification, targeted genetic testing, strengthening medical cooperation and maximizing local advantages in optimizing the management of HoFH especially within resource constraints, advocating for the establishment of a fast-track path for approval and supervision of new drugs for HoFH covered by official medical subsidies and LDL apheresis centers specialized for children in China.

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2026-11-19
DOI
https://doi.org/10.1186/s12887-026-07989-8
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Familial hypercholesterolemia complicated with multiple xanthomas in a child: a case report

Yingfen Qin, Jingqi Li
BMC Pediatrics
Lipoproteins and Cardiovascular Health
article

Familial hypercholesterolemia complicated with multiple xanthomas in a child: a case report

Yingfen Qin, Jingqi Li
article en

Abstract

Familial hypercholesterolemia (FH) is a hereditary disorder primarily due to variants of low-density lipoprotein receptor (LDLR) gene, characterized by markedly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels and a severely increased risk of premature atherosclerotic cardiovascular disease (ASCVD). For rare homozygous FH (HoFH), the condition is particularly severe and the treatment is extremely challenging. This case described a pediatric HoFH patient presenting with multiple xanthomas and a LDL-C level of 17.95 mmol/L (694.04 mg/dL). Genetic testing further revealed compound heterozygous variants in the LDLR gene: a missense variant (NM_000527.5:c.298G>A) and a classic splicing variant (NM_000527.5:c.817+1G>A), confirming the diagnosis of biallelic semidominant hypercholesterolemia, monogenic (same gene, different variants). The patient received triple combination therapy with atorvastatin, ezetimibe and evolocumab, and actively improved his lifestyle. After nearly two years of follow-up, his LDL-C levels decreased from baseline to 14.23 mmol/L (550.59 mg/dL). However, this failed to reach the therapeutic goal and cutaneous xanthomas at the joints showed no significant regression. For such patients with severe defects in LDLR function, agents independent of LDLR pathway, LDL apheresis, or even liver transplantation should be initiated early to improve long-term prognosis. This report underscores the role of prioritizing phenotypic identification, targeted genetic testing, strengthening medical cooperation and maximizing local advantages in optimizing the management of HoFH especially within resource constraints, advocating for the establishment of a fast-track path for approval and supervision of new drugs for HoFH covered by official medical subsidies and LDL apheresis centers specialized for children in China.

BMC Pediatrics
First Affiliated Hospital of GuangXi Medical University (CN)
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon